CuraGen names Shannon CEO

Cancer company CRGN promoted Timothy Shannon to president and CEO from EVP of R&D and CMO. Shannon replaces Frank Armstrong, who will remain a director. On Wednesday, CRGN was up $0.02 to $1.30. ...